Pfizer Inc plans to reorganise its research business once its takeover of Wyeth is complete. Research into new small-molecule drugs will be carried out in one unit and research into biologics and vaccines in another, the company announced.
Pfizer Inc plans to reorganise its research business once its takeover of Wyeth is complete. Research into new small-molecule drugs will be carried out in one unit and research into biologics and vaccines in another, the company announced.